107 related articles for article (PubMed ID: 12490848)
1. Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes.
Kendrick ML; Curlee K; Lloyd R; Farley DR; Grant CS; Thompson GB; Rowland C; Young WF; van Heerden JA
Surgery; 2002 Dec; 132(6):1008-11; discussion 1012. PubMed ID: 12490848
[TBL] [Abstract][Full Text] [Related]
2. Outcome of adrenocortical tumors in children.
Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.
Gonzalez RJ; Shapiro S; Sarlis N; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
Surgery; 2005 Dec; 138(6):1078-85; discussion 1085-6. PubMed ID: 16360394
[TBL] [Abstract][Full Text] [Related]
5. Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes.
O'Neill CJ; Spence A; Logan B; Suliburk JW; Soon PS; Learoyd DL; Sidhu SB; Sywak MS
J Surg Oncol; 2010 Oct; 102(5):450-3. PubMed ID: 20734420
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcome of stage III and IV adrenocortical carcinoma.
Ohwada S; Izumi M; Kawate S; Hamada K; Toya H; Togo N; Horiguchi J; Koibuchi Y; Takahashi T; Yamada M
Jpn J Clin Oncol; 2007 Feb; 37(2):108-13. PubMed ID: 17277000
[TBL] [Abstract][Full Text] [Related]
7. Surgical management and clinical prognosis of adrenocortical carcinoma.
Dong D; Li H; Yan W; Ji Z; Mao Q
Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience.
Tritos NA; Cushing GW; Heatley G; Libertino JA
Am Surg; 2000 Jan; 66(1):73-9. PubMed ID: 10651352
[TBL] [Abstract][Full Text] [Related]
9. [Adrenal carcinoma. Clinical and anatomopathological prognostic factors].
Boneschi M; Erba M; Beretta L; Miani S; Bortolani EM
Minerva Chir; 1998 Mar; 53(3):167-72. PubMed ID: 9617113
[TBL] [Abstract][Full Text] [Related]
10. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
11. Experience with the surgical treatment of adrenal cortical carcinoma.
Meyer A; Niemann U; Behrend M
Eur J Surg Oncol; 2004 May; 30(4):444-9. PubMed ID: 15063900
[TBL] [Abstract][Full Text] [Related]
12. [Surgical strategy in the treatment of adrenal cortex cancer. Expanded and repeated interventions].
Borrelli D; Bergamini C; Borrelli A; Reddavide S; Lassig R; Valeri A
Ann Ital Chir; 2003; 74(3):311-7. PubMed ID: 14677288
[TBL] [Abstract][Full Text] [Related]
13. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
[TBL] [Abstract][Full Text] [Related]
14. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.
Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070
[TBL] [Abstract][Full Text] [Related]
15. Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial.
Hubertus J; Boxberger N; Redlich A; von Schweinitz D; Vorwerk P
Klin Padiatr; 2012 Apr; 224(3):143-7. PubMed ID: 22504769
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
[TBL] [Abstract][Full Text] [Related]
17. Operative intervention for recurrent adrenocortical cancer.
Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
[TBL] [Abstract][Full Text] [Related]
18. Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery.
Hermsen IG; Kerkhofs TM; den Butter G; Kievit J; van Eijck CH; Nieveen van Dijkum EJ; Haak HR;
Surgery; 2012 Jul; 152(1):50-6. PubMed ID: 22703895
[TBL] [Abstract][Full Text] [Related]
19. Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.
Ronchi CL; Sbiera S; Kraus L; Wortmann S; Johanssen S; Adam P; Willenberg HS; Hahner S; Allolio B; Fassnacht M
Endocr Relat Cancer; 2009 Sep; 16(3):907-18. PubMed ID: 19240185
[TBL] [Abstract][Full Text] [Related]
20. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.
Molina JR; Aubry MC; Lewis JE; Wampfler JA; Williams BA; Midthun DE; Yang P; Cassivi SD
Cancer; 2007 Nov; 110(10):2253-9. PubMed ID: 17918258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
